The Cigna Group (NYSE:CI) Stock Holdings Raised by Broderick Brian C

Broderick Brian C raised its stake in The Cigna Group (NYSE:CI) by 18.9% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 951 shares of the health services provider’s stock after purchasing an additional 151 shares during the period. Broderick Brian C’s holdings in The Cigna Group were worth $345,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of CI. Silicon Valley Capital Partners lifted its stake in shares of The Cigna Group by 100.0% in the 1st quarter. Silicon Valley Capital Partners now owns 70 shares of the health services provider’s stock worth $25,000 after acquiring an additional 35 shares during the period. Fortitude Family Office LLC acquired a new stake in shares of The Cigna Group during the fourth quarter valued at approximately $29,000. VisionPoint Advisory Group LLC raised its holdings in shares of The Cigna Group by 112.2% during the third quarter. VisionPoint Advisory Group LLC now owns 104 shares of the health services provider’s stock valued at $30,000 after acquiring an additional 55 shares during the period. Raleigh Capital Management Inc. raised its holdings in shares of The Cigna Group by 69.5% during the fourth quarter. Raleigh Capital Management Inc. now owns 100 shares of the health services provider’s stock valued at $30,000 after acquiring an additional 41 shares during the period. Finally, Pineridge Advisors LLC acquired a new stake in shares of The Cigna Group during the fourth quarter valued at approximately $37,000. Institutional investors own 86.99% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on CI shares. JPMorgan Chase & Co. boosted their price target on shares of The Cigna Group from $432.00 to $435.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. Oppenheimer upped their price objective on shares of The Cigna Group from $370.00 to $400.00 and gave the company an “outperform” rating in a research note on Friday, May 3rd. Piper Sandler began coverage on shares of The Cigna Group in a research note on Wednesday, June 26th. They issued an “overweight” rating and a $400.00 price objective on the stock. StockNews.com lowered shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, June 12th. Finally, Baird R W upgraded shares of The Cigna Group to a “strong-buy” rating in a research note on Thursday, May 30th. Two analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, The Cigna Group presently has an average rating of “Buy” and a consensus price target of $376.20.

Insider Buying and Selling

In other The Cigna Group news, insider Noelle K. Eder sold 10,700 shares of the stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $348.47, for a total value of $3,728,629.00. Following the completion of the sale, the insider now directly owns 15,824 shares of the company’s stock, valued at approximately $5,514,189.28. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other The Cigna Group news, insider Brian C. Evanko sold 4,795 shares of the stock in a transaction on Monday, June 24th. The shares were sold at an average price of $345.01, for a total value of $1,654,322.95. Following the completion of the sale, the insider now directly owns 39,923 shares of the company’s stock, valued at approximately $13,773,834.23. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Noelle K. Eder sold 10,700 shares of the stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $348.47, for a total transaction of $3,728,629.00. Following the completion of the sale, the insider now directly owns 15,824 shares of the company’s stock, valued at $5,514,189.28. The disclosure for this sale can be found here. In the last three months, insiders sold 22,988 shares of company stock valued at $7,975,726. Company insiders own 0.70% of the company’s stock.

The Cigna Group Stock Performance

Shares of NYSE CI traded up $3.65 during trading hours on Thursday, hitting $333.56. 1,142,642 shares of the stock were exchanged, compared to its average volume of 1,609,497. The company has a debt-to-equity ratio of 0.75, a current ratio of 0.71 and a quick ratio of 0.71. The company’s 50 day moving average is $336.33 and its 200 day moving average is $334.82. The firm has a market capitalization of $94.75 billion, a P/E ratio of 27.39, a P/E/G ratio of 0.99 and a beta of 0.52. The Cigna Group has a one year low of $253.95 and a one year high of $365.71.

The Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, May 2nd. The health services provider reported $6.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.17 by $0.30. The business had revenue of $57.25 billion during the quarter, compared to the consensus estimate of $56.59 billion. The Cigna Group had a net margin of 1.76% and a return on equity of 17.24%. The Cigna Group’s quarterly revenue was up 23.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.41 EPS. On average, research analysts expect that The Cigna Group will post 28.48 EPS for the current year.

The Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 20th. Investors of record on Tuesday, June 4th were issued a dividend of $1.40 per share. This represents a $5.60 annualized dividend and a dividend yield of 1.68%. The ex-dividend date was Tuesday, June 4th. The Cigna Group’s dividend payout ratio is currently 45.98%.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.